Total Payments
$17,216
2024 Payments
$1,235
Companies
38
Transactions
699
Medicare Patients
6,421
Medicare Billing
$791,250
Payment Breakdown by Category
Food & Beverage$17,120 (99.4%)
Education$95.73 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,120 | 687 | 99.4% |
| Education | $95.73 | 12 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,604 | 131 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,126 | 83 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,023 | 65 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $1,396 | 33 | $0 (2022) |
| Allergan, Inc. | $1,356 | 79 | $0 (2020) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,350 | 79 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $871.05 | 17 | $0 (2024) |
| Novo Nordisk Inc | $860.92 | 35 | $0 (2023) |
| GlaxoSmithKline, LLC. | $705.74 | 16 | $0 (2024) |
| PFIZER INC. | $684.84 | 34 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,235 | 35 | AstraZeneca Pharmaceuticals LP ($608.87) |
| 2023 | $2,028 | 98 | ABBVIE INC. ($539.50) |
| 2022 | $2,173 | 107 | ABBVIE INC. ($646.71) |
| 2021 | $2,784 | 137 | AbbVie Inc. ($880.22) |
| 2020 | $1,261 | 65 | Boehringer Ingelheim Pharmaceuticals, Inc. ($275.81) |
| 2019 | $1,607 | 68 | Boehringer Ingelheim Pharmaceuticals, Inc. ($464.70) |
| 2018 | $3,521 | 101 | Boehringer Ingelheim Pharmaceuticals, Inc. ($703.37) |
| 2017 | $2,607 | 88 | Allergan Inc. ($444.46) |
All Payment Transactions
699 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $123.07 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $187.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $25.75 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/04/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $23.70 | General |
| Category: Cardiovascular | ||||||
| 08/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: Respiratory | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/13/2024 | Bayer Healthcare LLC | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: Cardio-renal | ||||||
| 07/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: Respiratory | ||||||
| 06/14/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/04/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Cardio-renal | ||||||
| 05/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/30/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.71 | General |
| Category: Cardiovascular | ||||||
| 04/11/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Insomnia | ||||||
| 04/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Respiratory | ||||||
| 04/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,298 | 2,984 | $348,295 | $175,049 |
| 2022 | 16 | 1,320 | 3,111 | $369,685 | $180,276 |
| 2021 | 17 | 1,729 | 3,977 | $445,985 | $225,869 |
| 2020 | 20 | 2,074 | 4,141 | $456,350 | $210,056 |
Total Patients
6,421
Total Services
14,213
Medicare Billing
$791,250
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 242 | 805 | $140,875 | $79,111 | 56.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 169 | 429 | $53,625 | $33,318 | 62.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 183 | 530 | $42,400 | $24,053 | 56.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 143 | 253 | $31,625 | $18,254 | 57.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 18 | 66 | $23,100 | $3,794 | 16.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 26 | 26 | $6,500 | $3,790 | 58.3% |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 2023 | 12 | 58 | $14,500 | $3,387 | 23.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 74 | 74 | $4,260 | $2,563 | 60.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 168 | 253 | $7,590 | $2,125 | 28.0% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 40 | 56 | $5,600 | $1,954 | 34.9% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 110 | 283 | $8,490 | $1,090 | 12.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 41 | 48 | $4,800 | $559.44 | 11.7% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 17 | 17 | $1,360 | $539.24 | 39.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 20 | 33 | $1,980 | $385.20 | 19.5% |
| 81002 | Urinalysis, manual test | Office | 2023 | 22 | 28 | $840.00 | $95.48 | 11.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 13 | 25 | $750.00 | $29.65 | 4.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 264 | 870 | $152,225 | $87,922 | 57.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 198 | 453 | $56,625 | $34,478 | 60.9% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 194 | 635 | $50,722 | $23,567 | 46.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 129 | 243 | $30,273 | $15,116 | 49.9% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 22 | 65 | $22,750 | $3,763 | 16.5% |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | Office | 2022 | 14 | 60 | $15,000 | $3,589 | 23.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 21 | 21 | $5,250 | $3,202 | 61.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 35 | 50 | $5,000 | $2,497 | 49.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $3,250 | $1,765 | 54.3% |
About Dr. Jesus Hernandez, MD
Dr. Jesus Hernandez, MD is a Physical Medicine & Rehabilitation healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1083750913.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jesus Hernandez, MD has received a total of $17,216 in payments from pharmaceutical and medical device companies, with $1,235 received in 2024. These payments were reported across 699 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($17,120).
As a Medicare-enrolled provider, Hernandez has provided services to 6,421 Medicare beneficiaries, totaling 14,213 services with total Medicare billing of $791,250. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties General Practice
- Location New York, NY
- Active Since 01/29/2007
- Last Updated 03/07/2023
- Taxonomy Code 208100000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083750913
Products in Payments
- VRAYLAR (Drug) $1,424
- JARDIANCE (Drug) $1,386
- LINZESS (Drug) $1,100
- XARELTO (Drug) $1,082
- FARXIGA (Drug) $1,036
- ELIQUIS (Drug) $867.42
- XIFAXAN (Drug) $858.96
- Kerendia (Drug) $446.88
- Ozempic (Drug) $416.66
- SYMBICORT (Drug) $377.68
- ZENPEP (Drug) $368.18
- TRULANCE (Drug) $366.14
- BREZTRI (Drug) $356.47
- INVOKANA (Drug) $307.68
- AREXVY (Drug) $304.72
- UBRELVY (Drug) $277.91
- QULIPTA (Drug) $275.21
- EUCRISA (Drug) $235.35
- NURTEC ODT (Drug) $226.37
- SPIRIVA RESPIMAT (Drug) $207.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in New York
Heidi Fusco, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $160,307
Physical Medicine & Rehabilitation $160,307
Dr. Kimberly Sackheim, Do, DO
Physical Medicine & Rehabilitation — Payments: $158,974
Physical Medicine & Rehabilitation $158,974
Michael O'dell, Md, MD
Physical Medicine & Rehabilitation — Payments: $103,549
Physical Medicine & Rehabilitation $103,549
Dr. Craig Antell, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $78,788
Physical Medicine & Rehabilitation $78,788
Russell Silver, Md, MD
Physical Medicine & Rehabilitation — Payments: $66,937
Physical Medicine & Rehabilitation $66,937
Ehsan Abdeshahian, Md, MD
Physical Medicine & Rehabilitation — Payments: $54,837
Physical Medicine & Rehabilitation $54,837